In celebration of Ophthalmology Times ' 50th anniversary, we asked leading experts in the field, in a perfect world, if they ...

Band optic atrophy is described as a horizontal band of optic disc pallor, often associated with a contralateral optic tract lesion and bilateral hemianopic visual field defects. Relative afferent ...

Autosomal dominant optic atrophy (ADOA), the most common genetic optic neuropathy, is an insidious disease. It often presents slowly during childhood by way of blurry vision, trouble reading or ...

A 57-year-old man with a history of bilateral traumatic optic atrophy resulting from a helicopter accident 20 years ago presented for follow-up. He had a new complaint of occasional, intermittent ...

The autosomal dominant optic atrophy (ADOA) treatment market is experiencing steady expansion, driven by growing disease awareness, advancements in diagnosis, and breakthrough therapies from key ...

Stoke Therapeutics Inc. has received clinical trial application (CTA) clearance from the U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) to initiate a phase I/II study (OSPREY) of ...

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression ...

BEDFORD, Mass.--(BUSINESS WIRE)--Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to addressing the underlying cause of severe diseases by upregulating protein expression ...